Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02414438 · ClinicalTrials.gov registry record · NA
Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study
A NA study, sponsored by Qure Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 217
- Enrollment target
NCT02414438: Completed NA study, sponsored by Qure Healthcare.
NCT02414438 is a NA study that has completed, run by Qure Healthcare. The registered enrollment target is 217 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02414438, a NA study, has completed, sponsored by Qure Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 217 participants
- Enrollment target
Study Summary
The study uses a randomized controlled study design of pediatric neurologists and developmental pediatricians and front-line (primary care) pediatricians to determine if use of FirstStepDx PLUS and Next StepDx PLUS are associated with higher clinical quality, less variability in clinical practice, and lower costs from decreased resource utilization. The Clinical Performance and Value Vignettes (CPV) used in this study simulate a clinical encounter for individuals with an atypical phenotype and clinical presentation indicative of a possible genetic disorder. We will measure the difference in combined diagnostic and treatment CPV® domain score post-intervention versus baseline comparing intervention and control groups
Primary Outcome
Differences in CPV diagnosis/treatment domain score post-intervention versus baseline for the intervention and control group physicians).
Interventions
- OTHER FirstStepDX PLUS and NextStepDX PLUS Webinar
- OTHER FirstStepDX PLUS and NextStepDX PLUS Test Results
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT02414438 record still lists
NCT02414438 is an interventional study that assigns participants to a tested intervention. The registered 217 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which FirstStepDX PLUS and NextStepDX PLUS Webinar is the first listed.
NCT02414438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02414438 about?
NCT02414438 is a clinical study titled "Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study". The study uses a randomized controlled study design of pediatric neurologists and developmental pediatricians and front-line (primary care) pediatricians to determine if use of FirstStepDx PLUS and Next StepDx PLUS are associated with higher clinical quality, less variability in clinical practice, a...
What is the current status of trial NCT02414438?
This trial is currently completed. It is a NA study. The enrollment target is 217 participants. The study started on 2014-08. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02414438?
The interventions under investigation include: FirstStepDX PLUS and NextStepDX PLUS Webinar (OTHER), FirstStepDX PLUS and NextStepDX PLUS Test Results (OTHER).
Who is sponsoring clinical trial NCT02414438?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02414438's enrollment target sits among peer trials
217 485th of 2000 higher than 1,516 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079282 · 217 participants · Phase 1
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
- NCT05470439 · 217 participants · NA
My Interprofessional Care Team for Adherence and Research Engagement Disparities
- NCT05981703 · 217 participants · Phase 1
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- NCT06342258 · 217 participants · Phase 1
COES: Curing Order Effects on Sealants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia